A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes

British Journal of Haematology

Volumn 103, Issue 4, 1998, Pages 1070-1074

  Ferrini, Pierluigi Rossi ^b   Grossi, Alberto ^a   Vannucchi, Alessandro M ^b   Barosi, Giovanni ^b   Guarnone, Roberta ^b   Piva, Nadia ^b   Musto, Pellegrino ^b   Balleari, Enrico ^b  

^a Division of Haematology   (Italy)

^b NONE

Author keywords

Anaemia; Erythropoietin; Myelodysplastic syndromes; Transferrin receptor; Transfusion

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERYTHROPOIESIS; FEMALE; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTORY ANEMIA; SIDEROBLASTIC ANEMIA;

ADULT; AGED; DOUBLE-BLIND METHOD; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RISK FACTORS;

EID: 0032409909     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01085.x     Document Type: Article

References (26)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
2. Bessho, M., Jinnai, I., Matsuda, A., Saito, M. & Hiroshima, K. (1990) Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. International Journal of Cell Cloning, 8, 445-458.
3. Bockheim, C. & Jassak, P.F. (1993) The expanding world of colony stimulating factors. Cancer Practice, 1, 205-213.
4. Bowen, D., Culligan, D. & Jacobs, A. (1991) The treatment of anaemia in myelodysplastic syndromes with recombinant human erythropoietin. British Journal of Haematology, 77, 455-459.
5. Cazzola, M., & Beguin, Y. (1992) New tools for clinical evaluation of erythropoiesis and iron status in man. British Journal of Haematology, 80, 278-284.
6. Goy, A., Belanger, C., Casadevall, N., Picard, F., Guesnu, M., Jaulmes, D., Poisson, D. & Varet, B. (1993) High doses of intravenous recombinant erythropoietin for the treatment of anaemia in myelodysplastic syndromes. British Journal of Haematology, 84, 232-237.
7. Greenberg, P.L. (1992) Treatment of myelodysplastic syndromes with hemopoietic growth factors. Seminars in Oncology, 19, 106-114.
8. Greenberg, P., Cox, C., Le Beau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennet, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079-2088.
9. Hellström-Lindberg, E. (1995) Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. British Journal of Haematology, 89, 67-71.
10. Hellström-Lindberg, E., et al (1998) Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long term follow-up of 71 patients. Blood, 92, 68-75.
11. Hellström-Lindberg, E., Birgegard, G., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, I., Grimfors, G., Merk, K., Tangen, J.M., Winqvist, I. & Ost, A. (1993) A combination of granulocyte-colony-stimulating factor and erythropoietin may synergistically improve the anemia in patients with myelodysplastic syndromes. Leukemia and Lymphoma, 11, 221-228.
12. Hellström-Lindberg, E., Negrin, R., Stein, R., Krantz, S., Lindberg, G., Vardiman, J., Ost, A. & Greenberg, P. (1997) Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. British Journal of Haematology, 99, 344-351.
13. Hoefsloot, L.H., van Amelsvoort, M.P., Broeders, L.C.A.M., van der Plas, D.C., van Lom, K., Hoogerbrugge, H., Touw, I.P. & Lowenberg, B. (1997) Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome. Blood, 89, 1690-1700.
14. Kurzrock, R., Talpaz, M., Estey, E., O'Brien, S., Estrov, Z. & Gutterman, J.U. (1991) Erythropoietin treatment in patients with myelodysplastic syndrome and anemia. Leukemia, 5, 985-990.
15. Mittelman, M., Gardyn, J., Carmel, M., Malovani, H., Barak, Y. & Nir, U. (1996) Analysis of the erythropoietin receptor gene in patients with myeloproliferative and myelodysplastic syndromes. Leukemia Research, 20, 459-466.
16. Mufti, J.G. & Galton, D.A.G. (1986) Myelodysplastic syndromes: natural history and featutes of prognostic importance. Clinical Haematology, 15, 953-972.
17. Musto, P., Modoni, S., Alicino, G., Savino, A., Longo, A., Bodenizza, C., Falcone, A., D'Arena, G., Scalzulli, P., Perla, G., Casparrini, G. & Carotenuto, M. (1994) Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence retyculocytes and hypochromic erythrocytes. Haematology, 79, 493-499.
18. Negrin, R.S., Stein, R., Vardiman, J., Doherty, K., Cornwell, J., Krantz, S. & Greenberg, P. (1993) Treatment of the anemia of myelodysplastic syndromes using human granulocyte-CSF in combination with erythropoietin. Blood, 82, 737-743.
19. Rafanelli, D., Grossi, A., Longo, G., Vannucchi, A.M., Bacci, P. & RossiFerrini, P. (1992) Recombinant human erythropoietin for treatment of myelodysplastic syndromes. Leukemia, 6, 323-327.
20. Rose, E.H., Abels, R.I., Nelson, R.A., McCullough, D.M. & Lessin, L. (1995) The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS). British Journal of Haematology, 89, 831-837.
21. Rowe, J.M. (1991) Myolodysplasia. Mediguide to Oncology, 11, (3), 1-12.
22. Stein, R.S., Abels, R.I. & Krantz, S.B. (1991) Pharmacological doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood, 78, 1658-1663.
23. Stenke, L., Willvik, J., Celsing, F. & Hast, R. (1993) Prediction of response to treatment with recombinant erythropoietin in myelodysplastic syndromes. Leukemia, 7, 1324-1327.
24. Third MIC Cooperative Study Group (1987) Morphologic, immunologic and cytogenetic (MIC) classification of the primary myelodysplastic syndromes and therapy-related myelodysplasia and leukemia. Cancer Genetics and Cytogenetics, 32, 1-10.
25. Van Kampf, H., Prinsze-Postema, T.C., Kluin, P.M., Den Ottolander, G.J., Willemze, R. & Willem, E.F. (1991) Effect of subcutaneosly administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia. British Journal of Haematology, 78, 488-493.
26. Verhoef, G., Zachée, P., Ferrant, A., Demuynk, D., Sellslag, D., van Hove, L., Deckers, F. & Boogaerts, M.A. (1992) Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: a clinical and erythrokinetic assessment. Annals of Haematology, 64, 16-21.